Clinical trials
Phase 3 Carcinoma, Medullary trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2008 | 1 |
| 2011 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Exelixis | 1 |
| Genzyme, a Sanofi Company | 1 |
| Hoffmann-La Roche | 1 |
| Loxo Oncology, Inc. | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| Sanofi | 1 |
| Vancouver Coastal Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Medullary | 8 |
| Thyroid Neoplasms | 2 |
| Carcinoid Tumor | 1 |
| Gastrinoma | 1 |
| Hypercalcemia | 1 |
| Insulinoma | 1 |
| Multiple Endocrine Neoplasia | 1 |
| Multiple Endocrine Neoplasia Type 2a | 1 |
| Neoplasm Metastasis | 1 |
| Neuroblastoma | 1 |
Trials
Showing 76 to 8 of 8. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.